持续性膀胱冲洗设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Continuous Bladder Irrigation Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年05月05日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024年，全球持续性膀胱冲洗装置市场规模达14亿美元，预计到2034年将以4.4%的复合年增长率增长，达到22亿美元，这主要得益于膀胱癌、血尿和良性前列腺增生 (BPH) 等泌尿系统疾病的日益流行。医疗保健提供者致力于减少併发症并改善患者康復，持续膀胱冲洗系统 (CBI) 已成为医院和临床环境中不可或缺的设备。这些系统在泌尿外科手术后的术后护理中尤其重要，因为它们有助于预防血栓形成并维持导管功能。

导管材料、设计和冲洗输送系统的技术进步显着改变了持续性膀胱冲洗 (CBI) 设备的功能和可靠性。防扭结导管、压力控制流动机制以及改进的球囊设计等创新技术提高了患者的安全性，并方便了临床医生的使用。这些进步有助于更好地控制尿流、减少导管阻塞并提高血块管理的有效性。此外，现代 CBI 系统还融入了可最大限度降低污染风险的功能，从而支持医院减少导管相关尿路感染 (CAUTI) 的努力。如今，医疗保健方案高度重视标准化的冲洗操作，因此，先进的 CBI 设备已成为术后和长期泌尿科护理中维持患者预后的关键组成部分。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	14亿美元
预测值	22亿美元
复合年增长率	4.4%

2024年，Foley三通导尿管占据最大市场份额，达58.3%，反映出其在术后出血管理和导管通畅维护方面的广泛应用。这些导尿管具有冲洗、球囊扩张和尿液引流功能，是治疗复杂泌尿系统疾病不可或缺的工具。除了术后应用外，这些导尿管还用于治疗创伤性膀胱损伤、化疗引起的膀胱炎和其他尿潴留併发症，从而扩大了其在全球医疗保健领域的应用。

2024年，医院领域在持续膀胱冲洗设备市场中占据最大份额，因为膀胱肿瘤切除术和前列腺手术等手术频率较高，需要持续冲洗以防止血栓滞留。随着对减少导管相关泌尿道感染 (CAUTI) 的关注度日益提高，医院正在增加对先进持续性膀胱冲洗系统 (CBI) 的投资，以确保病患安全和手术成功率。持续膀胱冲洗在最大程度减少术后併发症方面发挥着重要作用，已成为住院泌尿科护理的标准操作。

美国持续性膀胱冲洗设备市场规模预计将在2024年达到5.693亿美元，这主要得益于美国老龄人口的增长，前列腺肥大、膀胱癌和血尿的发病率不断上升，而这些疾病通常需要长期冲洗。这一人口趋势直接导致了膀胱相关手术（例如经尿道手术）的增加，这些手术需要可靠的术后冲洗。医院和外科中心优先考虑耐用、抗感染且易于维护的高品质冲洗系统。

康德乐 (Cardinal Health)、CR Bard、Sterimed、百特 (Baxter)、Advin Health Care、Teleflex、Angiplast、HEMC、Medline、Bactiguard、波士顿科学 (Boston Scientific)、Coloplast、AdvaCare、B. Braun 和 Vogt Medical 等主要参与者正在采取有针对性的策略来提升市场有占有率。这些策略包括导管材料的产品创新、与医疗机构的策略合作以及向新兴市场的扩张。各公司也强调感染控制功能，提供可客製化的解决方案，并投资研发以满足监管标准并改善护理效果。

产业生态系统分析
产业衝击力
- 成长动力
  - 泌尿系统疾病盛行率上升
  - 导管材料和灌溉技术的进步
  - 微创泌尿外科手术的采用日益增多
  - 老年人口不断增加
- 产业陷阱与挑战
  - 导管相关泌尿道感染的风险
  - 中低收入国家缺乏认识，获得先进泌尿科护理的机会有限
成长潜力分析
川普政府关税
- 对贸易的影响
  - 贸易量中断
  - 报復措施
- 对产业的影响
  - 供应方影响（原料）
    - 主要材料价格波动
    - 供应链重组
    - 生产成本影响
  - 需求面影响（售价）
    - 价格传导至终端市场
    - 市占率动态
    - 消费者反应模式
- 受影响的主要公司
- 策略产业反应
  - 供应链重组
  - 定价和产品策略
  - 政策参与
- 川普政府关税的前景和未来考虑
未来市场趋势
监管格局
波特的分析
PESTEL分析

第四章：竞争格局

介绍
竞争仪錶板
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第五章：市场估计与预测：按产品，2021 - 2034 年

主要趋势
Foley三通导管
- 硅胶导管
- 乳胶导管
配件
- 灌溉套装
- 滚轮夹
- 奥特莱斯包
灌溉袋

第六章：市场估计与预测：依最终用途，2021 - 2034 年

主要趋势
医院
长期照护机构
其他最终用途

第七章：市场估计与预测：按地区，2021 - 2034 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
拉丁美洲
- 墨西哥
- 巴西
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第八章：公司简介

AdvaCare
Advin Health Care
Angiplast
B. Braun
Bactiguard
Baxter
Boston Scientific
CR Bard
Cardinal Health
Coloplast
HEMC
Medline
Sterimed
Teleflex
Vogt Medical

简介目录

Product Code: 13711

The Global Continuous Bladder Irrigation Devices Market was valued at USD 1.4 billion in 2024 and is estimated to grow at a CAGR of 4.4% to reach USD 2.2 billion by 2034, driven by the increasing prevalence of urological conditions such as bladder cancer, hematuria, and benign prostatic hyperplasia (BPH). As healthcare providers aim to reduce complications and improve patient recovery, CBI systems have become essential in hospitals and clinical settings. These systems are particularly vital during post-operative care following urologic surgeries, as they help prevent clot formation and maintain catheter function.

Continuous Bladder Irrigation Devices Market - IMG1

Technological progress in catheter materials, design, and irrigation delivery systems has significantly transformed the functionality and reliability of continuous bladder irrigation (CBI) devices. Innovations such as anti-kink tubing, pressure-controlled flow mechanisms, and improved balloon designs have enhanced patient safety and clinician ease-of-use. These advancements contribute to better control of urine flow, reduced catheter blockages, and more effective clot management. Additionally, modern CBI systems incorporate features that minimize the risk of contamination, supporting hospitals' efforts to reduce catheter-associated urinary tract infections (CAUTIs). Healthcare protocols now place a strong emphasis on standardized irrigation practices, as a result, advanced CBI devices have become a critical component in maintaining patient outcomes in post-operative and long-term urological care.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$1.4 Billion
Forecast Value	$2.2 Billion
CAGR	4.4%

Foley 3-way catheters held the largest market share at 58.3% in 2024, reflecting their widespread adoption in managing post-surgical bleeding and maintaining catheter patency. These catheters are capable of irrigation, balloon inflation, and urine drainage, making them indispensable in treating complex urological conditions. Beyond their post-operative use, these catheters are also utilized in trauma-related bladder injuries, chemotherapy-induced cystitis, and other urinary retention complications, which have widened their application in healthcare worldwide.

The Hospitals segment in the continuous bladder irrigation devices market held the largest share in 2024 due to the high frequency of procedures like bladder tumor resections and prostate surgeries, which require consistent irrigation to prevent blood clot retention. With an increasing focus on reducing catheter-associated urinary tract infections (CAUTIs), hospitals are investing more in advanced CBI systems that support patient safety and surgical success. The role of continuous bladder irrigation in minimizing post-surgical complications has made it a standard element in inpatient urological care.

United States Continuous Bladder Irrigation Devices Market is expected to reach USD 569.3 million in 2024, driven by the country's expanding elderly population is experiencing higher rates of prostate enlargement, bladder cancer, and hematuria-conditions that often require long-term irrigation solutions. This demographic trend has directly contributed to an increase in bladder-related surgeries, such as transurethral procedures, which require reliable post-surgical irrigation. Hospitals and surgical centers prioritize high-quality irrigation systems that offer durability, infection resistance, and ease of maintenance.

Key players such as Cardinal Health, C. R. Bard, Sterimed, Baxter, Advin Health Care, Teleflex, Angiplast, HEMC, Medline, Bactiguard, Boston Scientific, Coloplast, AdvaCare, B. Braun, and Vogt Medical are adopting focused strategies to enhance market presence. These include product innovation in catheter materials, strategic partnerships with healthcare institutions, and expansion into emerging markets. Companies are also emphasizing infection-control features, offering customizable solutions, and investing in R&D to meet regulatory standards and improve care outcomes.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of urological disorders
  - 3.2.1.2 Advancements in catheter materials and irrigation technologies
  - 3.2.1.3 Growing adoption of minimally invasive urological procedures
  - 3.2.1.4 Growing geriatric population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Risk of catheter-associated urinary tract infections
  - 3.2.2.2 Lack of awareness and limited access to advanced urological care in LMICs
3.3 Growth potential analysis
3.4 Trump administration tariffs
- 3.4.1 Impact on trade
  - 3.4.1.1 Trade volume disruptions
  - 3.4.1.2 Retaliatory measures
- 3.4.2 Impact on the Industry
  - 3.4.2.1 Supply-side impact (raw materials)
    - 3.4.2.1.1 Price volatility in key materials
    - 3.4.2.1.2 Supply chain restructuring
    - 3.4.2.1.3 Production cost implications
  - 3.4.2.2 Demand-side impact (selling price)
    - 3.4.2.2.1 Price transmission to end markets
    - 3.4.2.2.2 Market share dynamics
    - 3.4.2.2.3 Consumer response patterns
- 3.4.3 Key companies impacted
- 3.4.4 Strategic industry responses
  - 3.4.4.1 Supply chain reconfiguration
  - 3.4.4.2 Pricing and product strategies
  - 3.4.4.3 Policy engagement
- 3.4.5 Outlook and future considerations trump administration tariffs
3.5 Future market trends
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Competitive dashboard
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Foley 3 way catheters
- 5.2.1 Silicone catheters
- 5.2.2 Latex catheters
5.3 Accessories
- 5.3.1 Irrigation set
- 5.3.2 Roller clamp
- 5.3.3 Outlet bags
5.4 Irrigation bags

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Long term care facilities
6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Mexico
- 7.5.2 Brazil
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE